South and Central America Custom Antibody Market Size, Share, and Analysis by 2028
Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028South and Central America Custom Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Service (Antibody Development, Antibody Production and Purification, and Antibody Fragmentation and Labelling); Type (Monoclonal Antibodies, Polyclonal Antibodies, and Other Custom Antibodies); Source (Mice, Rabbits, and Others); Research Area (Oncology, Immunology, Stem Cells, Infectious Diseases, Neurobiology, Cardiovascular Diseases, and Others); End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organizations)
- Report Date : Jul 2021
- Report Code : TIPRE00023707
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 156
The custom antibody market in South and Central America is expected to grow from US$ 23.9 million in 2021 to US$ 45.9 million by 2028; it is estimated to grow at a CAGR of 9.8% from 2021 to 2028.
Biotechnology companies have been prominently focusing on collaborations, partnerships, acquisitions, and financial aids or funding for making progress in the markets they serve. Moreover, the COVID-19 pandemic has served opportunities to players to make some important strategic decisions. Following are a few instances of market consolidations that has leveraged growth of custom antibodies market. - In January 2021, Morphic Therapeutic, a biotechnology company, collaborated with Janssen Pharmaceutical, Inc., a part of Johnson & Johnson Private Limited, to develop novel antibodies against third integrin target proteins (a family of ubiquitous receptors).
- In November 2020, Modern, Inc. received support from Nation Institutes of Health (NIH). The NIH has appointed a Data Safety Monitoring Board (DSMB) for Moderna, Inc.’s Phase 3 study of mRNA-1273. mRNA-1273 is being studied as vaccine against COVID-19. The study was conducted in collaboration with National Institute of Allergy and Infectious Diseases (NIAID), which is part of the NIH, and the BARDA, a part of the Office of the Assistant Secretary for Preparedness and Response at the US Department of Health and Human Services.
Although the impact of Covid-19 on antimicrobial resistance is currently impossible to predict, most studies describe extensive empirical use in contrast to a low frequency of bacterial co-infection and secondary infections. Antimicrobial exposure is a risk factor for microbial resistance development. Furthermore, prolonged hospitalization with intensive care unit stays raises the risk of infections with multidrug-resistant bacteria. Antimicrobial stewardship is one of the most critical measures for lowering this risk. Moreover, in March 2020, Hi Technologies, a Curitiba-based biotech firm, launched a test to detect coronavirus (Covid-19). The test is performed using a person's blood sample in the form of a capsule into the Nespresso-like machines. Its system is set to identify the antibodies that are reacting to coronavirus. According to SINDUSFARMA, the pharmaceutical sector in Brazil is highly robust. Every manufacturer can compete with any major corporation in the world's key markets. So much so that national enterprises now account for 65 percent of the market. Cimed also produces more than 10% of pharmaceuticals, with 450 million boxes in a $4 billion market. We also create 7 billion drugs in dosages. Almost every resident receives a dosage. In addition, the facility focuses on the areas of medical research during the COVID pandemic.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the custom antibody market. The South and Central America Custom antibody market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
South and Central America Custom Antibody Market Segmentation
By Service
- Antibody Development
- Antibody Production and Purification
- Antibody Fragmentation and Labelling
By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Other Custom Antibodies
By Source
- Mice
- Rabbits
- Others
By Research Area
- Oncology
- Immunology
- Stem Cells
- Infectious Diseases
- Neurobiology
- Cardiovascular Diseases
- Others
By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
By Country
- South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Merck KGAA
- Abcam
- Genscript
- Agilent Technologies, Inc.
South and Central America Custom Antibody Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 23.9 Million |
| Market Size by 2028 | US$ 45.9 Million |
| Global CAGR (2021 - 2028) | 9.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Service
|
| Regions and Countries Covered | South and Central America
|
| Market leaders and key company profiles |
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Merck KGAA
- Abcam
- Genscript
- Agilent Technologies, Inc.
Get Free Sample For